Revelation Biosciences, Inc.(REVB)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

REVB Revelation Biosciences, Inc.

交易中 01-08 14:40:08 EST

0.9000

-0.0103

-1.13%

最高0.9300	最低0.8941	成交量4.83万
今开0.9300	昨收0.9103	日振幅3.94%
总市值533.17万	流通市值209.16万	总股本592.41万
成交额4.38万	换手率2.08%	流通股本232.40万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"REVB","market":"US","secType":"STK","nameCN":"Revelation Biosciences, Inc.","latestPrice":0.9,"timestamp":1767901177851,"preClose":0.9103,"halted":0,"volume":48280,"delay":0,"floatShares":2324000,"shares":5924137,"eps":-30.005,"marketStatus":"交易中","change":-0.0103,"latestTime":"01-08 14:40:08 EST","open":0.93,"high":0.93,"low":0.8941,"amount":43833.2352952,"amplitude":0.039438,"askPrice":0.9195,"askSize":500,"bidPrice":0.9001,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-30.005,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1767906000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.9103,"preHourTrading":{"tag":"盘前","latestPrice":0.9124,"preClose":0.9103,"latestTime":"08:10 EST","volume":214,"amount":195.37960320000002,"timestamp":1767877806174},"postHourTrading":{"tag":"盘后","latestPrice":0.875,"preClose":0.9103,"latestTime":"19:30 EST","volume":1276,"amount":1133.4805,"timestamp":1767832247064},"volumeRatio":0.41956},"requestUrl":"/m/hq/s/REVB","defaultTab":"news","newsList":[{"id":"2601772008","title":"Revelation Biosciences, Inc.盘中异动 下午盘股价大涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601772008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601772008?lang=zh_cn&edition=full","pubTime":"2026-01-07 03:39","pubTimestamp":1767728378,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日03时39分，Revelation Biosciences, Inc.股票出现异动，股价大幅上涨6.08%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Alumis Inc.、Cyclerion Therapeutics, Inc.、Acrivon Therapeutics, Inc.涨幅较大，Pmgc Holdings Inc.、Cyclerion Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为2398.35%、1780.02%、240.88%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Alumis Inc.，振幅分别为297.37%、161.40%、84.56%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107033939953c19da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107033939953c19da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","REVBU","BK4139","REVBW"],"gpt_icon":0},{"id":"2587673152","title":"Revelation Biosciences, Inc.盘中异动 早盘股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2587673152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587673152?lang=zh_cn&edition=full","pubTime":"2025-11-28 23:08","pubTimestamp":1764342518,"startTime":"0","endTime":"0","summary":"北京时间2025年11月28日23时08分，Revelation Biosciences, Inc.股票出现异动，股价急速上涨5.34%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。Gemini是Revelation的专有配方，为磷酸化的六酰二糖，是一种已知的TLR4激动剂，可以刺激人体的先天免疫反应以预防和治疗疾病。所开发的产品候选者均基于Gemini配方的PHAD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128230838a4c0b647&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128230838a4c0b647&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBW","BK4139","REVBU","REVB"],"gpt_icon":0},{"id":"1132532915","title":"Revelation Biosciences, Inc. 第三季度每股收益为 -1.77 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1132532915","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132532915?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:01","pubTimestamp":1763571671,"startTime":"0","endTime":"0","summary":"11月6日 - Revelation Biosciences, Inc. 第三季度净收入为 -190 万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REVB","BK4139"],"gpt_icon":0},{"id":"2583501146","title":"Revelation Biosciences, Inc.盘中异动 下午盘快速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583501146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583501146?lang=zh_cn&edition=full","pubTime":"2025-11-14 02:01","pubTimestamp":1763056914,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日02时01分，Revelation Biosciences, Inc.股票出现异动，股价大幅下挫5.14%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Mersana Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、冠科美博涨幅较大，Clearmind Medicine Inc.、Salarius Pharmaceuticals, Inc.、Outlook Therapeutics, Inc.较为活跃，换手率分别为5233.34%、465.46%、94.61%，振幅较大的相关个股有Clearmind Medicine Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Outlook Therapeutics, Inc.，振幅分别为107.67%、45.96%、36.72%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114020154a6f79401&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114020154a6f79401&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBW","REVBU","BK4139","REVB"],"gpt_icon":0},{"id":"2578573094","title":"Revelation Biosciences, Inc.盘中异动 股价大涨7.44%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578573094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578573094?lang=zh_cn&edition=full","pubTime":"2025-10-24 23:32","pubTimestamp":1761319974,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日23时32分，Revelation Biosciences, Inc.股票出现波动，股价快速上涨7.44%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Theriva Biologics, Inc.、Genenta Science Spa、Inhibrx Biosciences, Inc.涨幅较大，Neuphoria Therapeutics Inc.、Qualigen Therapeutics, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为3107.40%、2328.53%、1869.33%，振幅较大的相关个股有Theriva Biologics, Inc.、Genenta Science Spa、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为134.04%、133.75%、84.64%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102423325494dbdd93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102423325494dbdd93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBU","REVBW","REVB","BK4139"],"gpt_icon":0},{"id":"2566569768","title":"Revelation Biosciences, Inc.盘中异动 早盘大幅下跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566569768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566569768?lang=zh_cn&edition=full","pubTime":"2025-09-08 21:33","pubTimestamp":1757338386,"startTime":"0","endTime":"0","summary":"北京时间2025年09月08日21时33分，Revelation Biosciences, Inc.股票出现异动，股价快速下跌5.20%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Rapport Therapeutics, Inc.、Genprex, Inc.、Ethzilla Corporation C/Wts 06/11/2025涨幅较大，Cdt Equity Inc.、Genprex, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为710.17%、95.21%、63.11%，振幅较大的相关个股有Rapport Therapeutics, Inc.、Genprex, Inc.、Alphaton Capital Corp.，振幅分别为29.72%、24.75%、11.59%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090821330697813eb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090821330697813eb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","REVBW","BK4139","REVBU"],"gpt_icon":0},{"id":"2558166590","title":"Revelation Biosciences, Inc.盘中异动 急速上涨5.46%报2.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558166590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558166590?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:34","pubTimestamp":1754919248,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时34分，Revelation Biosciences, Inc.股票出现异动，股价大幅拉升5.46%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Entero Therapeutics Inc.、Sonnet Biotherapeutics Holdings, Inc.、Artelo Biosciences, Inc.涨幅较大，Entero Therapeutics Inc.、Io Biotech, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为1870.33%、77.51%、27.61%，振幅较大的相关个股有Entero Therapeutics Inc.、Nucana Plc、Io Biotech, Inc.，振幅分别为35.90%、13.66%、11.88%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811213408a482176e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811213408a482176e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","BK4139","REVBW","REVBU"],"gpt_icon":0},{"id":"2557338745","title":"Revelation Biosciences, Inc.盘中异动 股价大涨5.04%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557338745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557338745?lang=zh_cn&edition=full","pubTime":"2025-08-04 23:22","pubTimestamp":1754320969,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日23时22分，Revelation Biosciences, Inc.股票出现异动，股价快速上涨5.04%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd.、凯信远达涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5342.47%、1362.75%、534.88%，振幅较大的相关个股有凯信远达、Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为92.95%、84.21%、46.43%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080423225094cf1a7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080423225094cf1a7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVBU","REVBW","REVB"],"gpt_icon":0},{"id":"2555230370","title":"Revelation Biosciences, Inc.盘中异动 急速上涨5.26%报2.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555230370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555230370?lang=zh_cn&edition=full","pubTime":"2025-07-31 00:14","pubTimestamp":1753892054,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日00时14分，Revelation Biosciences, Inc.股票出现异动，股价快速上涨5.26%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Replimune Group, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Tnf Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.、Replimune Group, Inc.较为活跃，换手率分别为372.81%、207.59%、179.56%，振幅较大的相关个股有Replimune Group, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为54.00%、53.86%、47.44%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073100141494c438e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073100141494c438e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","BK4139","REVBW","REVBU"],"gpt_icon":0},{"id":"2555703314","title":"Revelation Biosciences, Inc.盘中异动 股价大跌5.03%报2.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555703314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555703314?lang=zh_cn&edition=full","pubTime":"2025-07-29 00:05","pubTimestamp":1753718728,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日00时05分，Revelation Biosciences, Inc.股票出现异动，股价快速下挫5.03%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Celcuity Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃，换手率分别为480.20%、256.90%、127.03%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为137.86%、82.93%、75.48%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072900052994bfa719&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072900052994bfa719&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVBW","REVBU","REVB"],"gpt_icon":0},{"id":"2552361164","title":"Revelation Biosciences, Inc.盘中异动 急速下挫5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552361164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552361164?lang=zh_cn&edition=full","pubTime":"2025-07-18 02:24","pubTimestamp":1752776684,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日02时24分，Revelation Biosciences, Inc.股票出现波动，股价快速下挫5.60%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，180 Life Sciences Corp.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Windtree Therapeutics, Inc.、Marker Therapeutics, Inc.、180 Life Sciences Corp.较为活跃，换手率分别为977.48%、538.00%、418.58%，振幅较大的相关个股有Marker Therapeutics, Inc.、180 Life Sciences Corp.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为148.12%、96.60%、95.69%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718022444a451a058&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718022444a451a058&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBW","REVB","REVBU","BK4139"],"gpt_icon":0},{"id":"2551262821","title":"Revelation Biosciences, Inc.盘中异动 快速拉升5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551262821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551262821?lang=zh_cn&edition=full","pubTime":"2025-07-16 22:32","pubTimestamp":1752676362,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日22时32分，Revelation Biosciences, Inc.股票出现异动，股价急速上涨5.23%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.09%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716223242a44efa2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716223242a44efa2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBW","REVBU","BK4139","REVB"],"gpt_icon":0},{"id":"2551601151","title":"Revelation Biosciences, Inc.盘中异动 股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551601151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551601151?lang=zh_cn&edition=full","pubTime":"2025-07-15 21:35","pubTimestamp":1752586514,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日21时35分，Revelation Biosciences, Inc.股票出现波动，股价快速上涨5.45%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。Gemini是Revelation的专有配方，为磷酸化的六酰二糖，是一种已知的TLR4激动剂，可以刺激人体的先天免疫反应以预防和治疗疾病。所开发的产品候选者均基于Gemini配方的PHAD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715213514a44c8dae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715213514a44c8dae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVB","REVBU","REVBW"],"gpt_icon":0},{"id":"2518206835","title":"Revelation Biosciences, Inc.盘中异动 下午盘大幅下挫5.44%报3.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518206835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518206835?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:41","pubTimestamp":1741628510,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时41分，Revelation Biosciences, Inc.股票出现波动，股价快速下挫5.44%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。Gemini 是 Revelation 的磷酸化六酰二糖  的专有配方，PHAD 是一种成熟的 TLR4 激动剂，可以刺激人体的先天免疫反应来预防和治疗疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311014150964067e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311014150964067e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBW","REVBU","BK4139","REVB"],"gpt_icon":0},{"id":"2518811592","title":"Revelation Biosciences, Inc.2024财年实现净利润-15.04百万美元，同比减少12406.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518811592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518811592?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536087,"startTime":"0","endTime":"0","summary":"3月10日，Revelation Biosciences, Inc.公布财报，公告显示公司2024财年净利润为-15.04百万美元，同比减少12406.86%；其中营业收入为0.00美元，每股基本收益为-87.68美元。机构评级：截至2025年3月10日，当前有2家机构对Revelation Biosciences, Inc.目标价做出预测，其中目标均价为170.72美元，其中最低目标价为21.45美元，最高目标价为320.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000315a26898a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000315a26898a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","REVBU","REVBW"],"gpt_icon":0},{"id":"1134026864","title":"Revelation生物技术公司第四季度每股收益为$-4.98","url":"https://stock-news.laohu8.com/highlight/detail?id=1134026864","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134026864?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:30","pubTimestamp":1741296640,"startTime":"0","endTime":"0","summary":"Revelation生物技术公司第四季度每股收益为$-4.98以上内容来自Benzinga Earnings专栏，原文如下：Revelation Biosciences Q4 EPS $(4.98)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REVB"],"gpt_icon":0},{"id":"2516603819","title":"Revelation Biosciences, Inc.盘中异动 大幅下挫7.16%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516603819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516603819?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:15","pubTimestamp":1741101319,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时15分，Revelation Biosciences, Inc.股票出现波动，股价大幅下跌7.16%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。Gemini 是 Revelation 的磷酸化六酰二糖  的专有配方，PHAD 是一种成熟的 TLR4 激动剂，可以刺激人体的先天免疫反应来预防和治疗疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231520a25f1216&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231520a25f1216&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVB","REVBU","REVBW"],"gpt_icon":0},{"id":"2516650984","title":"Revelation Biosciences, Inc.盘中异动 快速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516650984","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516650984?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:31","pubTimestamp":1741030280,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时31分，Revelation Biosciences, Inc.股票出现异动，股价大幅上涨5.13%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4544.75%、206.64%、181.12%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304033121989a51ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304033121989a51ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBU","REVB","REVBW","BK4139"],"gpt_icon":0},{"id":"2514581376","title":"Revelation Biosciences, Inc.盘中异动 早盘股价大跌5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514581376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514581376?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:36","pubTimestamp":1740756992,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时36分，Revelation Biosciences, Inc.股票出现异动，股价急速下挫5.79%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Bioxcel Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Enveric Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1717.03%、413.65%、345.93%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Bioxcel Therapeutics, Inc.，振幅分别为46.60%、43.37%、41.62%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282336329896884b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282336329896884b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBU","REVB","REVBW","BK4139"],"gpt_icon":0},{"id":"2514386763","title":"Revelation Biosciences, Inc.盘中异动 早盘快速下跌5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386763?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:00","pubTimestamp":1740668450,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时00分，Revelation Biosciences, Inc.股票出现波动，股价快速下挫5.55%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。Gemini 是 Revelation 的磷酸化六酰二糖  的专有配方，PHAD 是一种成熟的 TLR4 激动剂，可以刺激人体的先天免疫反应来预防和治疗疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227230050abdf767f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227230050abdf767f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVB","REVBU","REVBW"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revbiosciences.com","stockEarnings":[{"period":"1week","weight":0.1382},{"period":"1month","weight":-0.1372},{"period":"3month","weight":-0.3807},{"period":"6month","weight":-0.6737},{"period":"1year","weight":-0.969},{"period":"ytd","weight":0.1382}],"compareEarnings":[{"period":"1week","weight":0.0112},{"period":"1month","weight":0.0087},{"period":"3month","weight":0.0274},{"period":"6month","weight":0.1058},{"period":"1year","weight":0.1715},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Revelation Biosciences, Inc.是一家特拉华州公司，成立于2019年11月20日。该公司是一家临床阶段的生命科学公司，专注于开发用于预防和治疗疾病的免疫疗法。Revelation有几个正在开发的候选产品。REVTx-99是主要的治疗候选药物，是一种鼻内免疫调节剂，用于预防或治疗由各种呼吸道病毒引起的感染。REVTx-99也正在开发用于其他适应症，例如：过敏性鼻炎和慢性鼻塞。REVTx-200是一种鼻内免疫调节剂辅助剂，可与肌肉注射疫苗联合使用，以获得更完全的免疫。Revelation还在开发REVDx-501，这是一种快速的家用诊断工具，可用于检测任何呼吸道病毒感染，无需专门的仪器。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.155619},{"month":2,"riseRate":0.2,"avgChangeRate":-0.384065},{"month":3,"riseRate":0,"avgChangeRate":-0.210884},{"month":4,"riseRate":0.4,"avgChangeRate":-0.080222},{"month":5,"riseRate":0,"avgChangeRate":-0.257093},{"month":6,"riseRate":0.4,"avgChangeRate":0.177022},{"month":7,"riseRate":0.2,"avgChangeRate":-0.130551},{"month":8,"riseRate":0.4,"avgChangeRate":-0.132636},{"month":9,"riseRate":0.4,"avgChangeRate":-0.212261},{"month":10,"riseRate":0.6,"avgChangeRate":-0.028205},{"month":11,"riseRate":0.4,"avgChangeRate":-0.088914},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.150121}],"exchange":"NASDAQ","name":"Revelation Biosciences, Inc.","nameEN":"Revelation Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Revelation Biosciences, Inc.(REVB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Revelation Biosciences, Inc.(REVB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Revelation Biosciences, Inc.,REVB,Revelation Biosciences, Inc.股票,Revelation Biosciences, Inc.股票老虎,Revelation Biosciences, Inc.股票老虎国际,Revelation Biosciences, Inc.行情,Revelation Biosciences, Inc.股票行情,Revelation Biosciences, Inc.股价,Revelation Biosciences, Inc.股市,Revelation Biosciences, Inc.股票价格,Revelation Biosciences, Inc.股票交易,Revelation Biosciences, Inc.股票购买,Revelation Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Revelation Biosciences, Inc.(REVB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Revelation Biosciences, Inc.(REVB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况